The Endpoints 11 list for 2025 celebrates 11 of the most promising biotech startups poised to shape the industry's future. Companies include Chai Discovery focusing on AI-driven drug design, Umoja Biopharma tackling in vivo CAR-T therapies, Candid Therapeutics advancing autoimmune T-cell engagers, Orbis Medicines developing macrocycle drugs as oral biologics, and others conferring innovations across oncology, gene therapies, and AI-powered science.